These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 19354203

  • 41. Identification of novel fragment compounds targeted against the pY pocket of v-Src SH2 by computational and NMR screening and thermodynamic evaluation.
    Taylor JD, Gilbert PJ, Williams MA, Pitt WR, Ladbury JE.
    Proteins; 2007 Jun 01; 67(4):981-90. PubMed ID: 17393456
    [Abstract] [Full Text] [Related]

  • 42. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M, Spadola L, Lundquist B, Hawtin P, Dahmén J, Groth-Clausen I, Nilsson E, Persdotter S, von Wachenfeldt K, Folmer RH, Edman K.
    J Med Chem; 2008 Apr 10; 51(7):2178-86. PubMed ID: 18341273
    [Abstract] [Full Text] [Related]

  • 43. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
    Cosconati S, Marinelli L, La Motta C, Sartini S, Da Settimo F, Olson AJ, Novellino E.
    J Med Chem; 2009 Sep 24; 52(18):5578-81. PubMed ID: 19719141
    [Abstract] [Full Text] [Related]

  • 44. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T, Frecer V, De-Eknamkul W, Hannongbua S, Miertus S.
    Antiviral Res; 2009 Apr 24; 82(1):51-8. PubMed ID: 19428595
    [Abstract] [Full Text] [Related]

  • 45. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D, Fogel GB.
    J Chem Inf Model; 2009 Apr 24; 49(4):1105-21. PubMed ID: 19348414
    [Abstract] [Full Text] [Related]

  • 46. FieldChopper, a new tool for automatic model generation and virtual screening based on molecular fields.
    Kalliokoski T, Ronkko T, Poso A.
    J Chem Inf Model; 2008 Jun 24; 48(6):1131-7. PubMed ID: 18489083
    [Abstract] [Full Text] [Related]

  • 47. Docking and scoring with alternative side-chain conformations.
    Hartmann C, Antes I, Lengauer T.
    Proteins; 2009 Feb 15; 74(3):712-26. PubMed ID: 18704939
    [Abstract] [Full Text] [Related]

  • 48. Structure-based calculation of drug efficiency indices.
    Hetényi C, Maran U, García-Sosa AT, Karelson M.
    Bioinformatics; 2007 Oct 15; 23(20):2678-85. PubMed ID: 17804436
    [Abstract] [Full Text] [Related]

  • 49. Scoring ligand similarity in structure-based virtual screening.
    Zavodszky MI, Rohatgi A, Van Voorst JR, Yan H, Kuhn LA.
    J Mol Recognit; 2009 Oct 15; 22(4):280-92. PubMed ID: 19235177
    [Abstract] [Full Text] [Related]

  • 50. A scalable approach to combinatorial library design for drug discovery.
    Sharma P, Salapaka S, Beck C.
    J Chem Inf Model; 2008 Jan 15; 48(1):27-41. PubMed ID: 18052333
    [Abstract] [Full Text] [Related]

  • 51. Library screening by fragment-based docking.
    Huang D, Caflisch A.
    J Mol Recognit; 2010 Jan 15; 23(2):183-93. PubMed ID: 19718684
    [Abstract] [Full Text] [Related]

  • 52. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
    Bharatham K, Bharatham N, Park KH, Lee KW.
    J Mol Graph Model; 2008 Jun 15; 26(8):1202-12. PubMed ID: 18096420
    [Abstract] [Full Text] [Related]

  • 53. Noise reduction method for molecular interaction energy: application to in silico drug screening and in silico target protein screening.
    Fukunishi Y, Kubota S, Nakamura H.
    J Chem Inf Model; 2006 Jun 15; 46(5):2071-84. PubMed ID: 16995738
    [Abstract] [Full Text] [Related]

  • 54. Optimization of the MAD algorithm for virtual screening.
    Eckert H, Bajorath J.
    Methods Mol Biol; 2008 Jun 15; 453():349-62. PubMed ID: 18712313
    [Abstract] [Full Text] [Related]

  • 55. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D, Baber JC, Feyfant E, Thompson DC, Humblet C.
    Curr Opin Drug Discov Devel; 2007 May 15; 10(3):264-74. PubMed ID: 17554852
    [Abstract] [Full Text] [Related]

  • 56. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.
    Schneider G, Nettekoven M.
    J Comb Chem; 2003 May 15; 5(3):233-7. PubMed ID: 12739938
    [Abstract] [Full Text] [Related]

  • 57. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H, Jung SK, Jeong DG, Ryu SE, Kim SJ.
    ChemMedChem; 2008 Jun 15; 3(6):877-80. PubMed ID: 18236492
    [No Abstract] [Full Text] [Related]

  • 58. A kinase-focused compound collection: compilation and screening strategy.
    Sun D, Chuaqui C, Deng Z, Bowes S, Chin D, Singh J, Cullen P, Hankins G, Lee WC, Donnelly J, Friedman J, Josiah S.
    Chem Biol Drug Des; 2006 Jun 15; 67(6):385-94. PubMed ID: 16882313
    [Abstract] [Full Text] [Related]

  • 59. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
    Jhoti H, Cleasby A, Verdonk M, Williams G.
    Curr Opin Chem Biol; 2007 Oct 15; 11(5):485-93. PubMed ID: 17851109
    [Abstract] [Full Text] [Related]

  • 60. Fragments, network biology and designing multiple ligands.
    Morphy R, Rankovic Z.
    Drug Discov Today; 2007 Feb 15; 12(3-4):156-60. PubMed ID: 17275736
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.